Publication: TRAF3 signaling: Competitive binding and evolvability of adaptive viral molecular mimicry
dc.contributor.coauthor | Guven-Maiorov, Emine | |
dc.contributor.coauthor | VanWaes, Carter | |
dc.contributor.coauthor | Chen, Zhong | |
dc.contributor.coauthor | Tsai, Chung-Jung | |
dc.contributor.coauthor | Nussinov, Ruth | |
dc.contributor.department | Department of Chemical and Biological Engineering | |
dc.contributor.department | Department of Computer Engineering | |
dc.contributor.kuauthor | Keskin, Özlem | |
dc.contributor.kuauthor | Gürsoy, Attila | |
dc.contributor.kuprofile | Faculty Member | |
dc.contributor.kuprofile | Faculty Member | |
dc.contributor.other | Department of Chemical and Biological Engineering | |
dc.contributor.other | Department of Computer Engineering | |
dc.contributor.researchcenter | The Center for Computational Biology and Bioinformatics (CCBB) | |
dc.contributor.schoolcollegeinstitute | College of Engineering | |
dc.contributor.schoolcollegeinstitute | College of Engineering | |
dc.contributor.yokid | 26605 | |
dc.contributor.yokid | 8745 | |
dc.date.accessioned | 2024-11-10T00:02:31Z | |
dc.date.issued | 2016 | |
dc.description.abstract | Background: The tumor necrosis factor receptor (TNFR) associated factor 3 (TRAF3) is a key node in innate and adaptive immune signaling pathways. TRAF3 negatively regulates the activation of the canonical and non canonical NF-kappa B pathways and is one of the key proteins in antiviral immunity. Scope of Review: Here we provide a structural overview of TRAF3 signaling in terms of its competitive binding and consequences to the cellular network. For completion, we also include molecular mimicry of TRAF3 physiological partners by some viral proteins. Major Conclusions: By out-competing host partners, viral proteins aim to subvert TRAF3 antiviral action. Mechanistically, dynamic, competitive binding by the organism's own proteins and same-site adaptive pathogen mimicry follow the same conformational selection principles. General Significance: Our premise is that irrespective of the eliciting event - physiological or acquired pathogenic trait - pathway activation (or suppression) may embrace similar conformational principles. However, even though here we largely focus on competitive binding at a shared site, similar to physiological signaling other pathogen subversion mechanisms can also be at play. This article is part of a Special Issue entitled "System Genetics" Guest Editor: Dr. Yudong Cai and Dr. Tao Huang. | |
dc.description.indexedby | WoS | |
dc.description.indexedby | Scopus | |
dc.description.indexedby | PubMed | |
dc.description.issue | 11 | |
dc.description.openaccess | YES | |
dc.description.publisherscope | International | |
dc.description.sponsorship | Federal funds from the National Cancer Institute, National Institutes of Health [HHSN261200800001E] | |
dc.description.sponsorship | NIDCD [ZIA-DC-000016, 73, 74] | |
dc.description.sponsorship | Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research This project has been funded in whole or in part with Federal funds from the National Cancer Institute, National Institutes of Health, under contract number HHSN261200800001E, and NIDCD intramural projects ZIA-DC-000016, 73 and 74. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. This research was supported (in part) by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research. O.K. and A.G. acknowledge Science Academy (of Turkey). | |
dc.description.volume | 1860 | |
dc.identifier.doi | 10.1016/j.bbagen.2016.05.021 | |
dc.identifier.eissn | 1872-8006 | |
dc.identifier.issn | 0304-4165 | |
dc.identifier.quartile | Q2 | |
dc.identifier.scopus | 2-s2.0-84973878591 | |
dc.identifier.uri | http://dx.doi.org/10.1016/j.bbagen.2016.05.021 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14288/16159 | |
dc.identifier.wos | 383825000005 | |
dc.keywords | Inflammation | |
dc.keywords | Cancer | |
dc.keywords | Antiviral immunity | |
dc.keywords | Evolvable | |
dc.keywords | Structure | |
dc.keywords | Host-pathogen interactions | |
dc.keywords | Protein-protein interactions | |
dc.keywords | I interferon-production | |
dc.keywords | Kappa-b activation | |
dc.keywords | Sars-coronavirus | |
dc.keywords | Interaction network | |
dc.keywords | Multiple-myeloma | |
dc.keywords | Cross-talk | |
dc.keywords | Receptor | |
dc.keywords | Ubiquitination | |
dc.keywords | Recognition | |
dc.language | English | |
dc.publisher | Elsevier | |
dc.source | Biochimica et Biophysica Acta-General Subjects | |
dc.subject | Biochemistry | |
dc.subject | Molecular Biology | |
dc.subject | Biophysics | |
dc.title | TRAF3 signaling: Competitive binding and evolvability of adaptive viral molecular mimicry | |
dc.type | Journal Article | |
dspace.entity.type | Publication | |
local.contributor.authorid | 0000-0002-4202-4049 | |
local.contributor.authorid | 0000-0002-2297-2113 | |
local.contributor.kuauthor | Keskin, Özlem | |
local.contributor.kuauthor | Gürsoy, Attila | |
relation.isOrgUnitOfPublication | c747a256-6e0c-4969-b1bf-3b9f2f674289 | |
relation.isOrgUnitOfPublication | 89352e43-bf09-4ef4-82f6-6f9d0174ebae | |
relation.isOrgUnitOfPublication.latestForDiscovery | 89352e43-bf09-4ef4-82f6-6f9d0174ebae |